This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (7)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Peter D. Kleinman, MD; Paul F. Griner, MD

Arch Intern Med. 1970;126(3):522-523.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In recent years, a number of drugs have been identified which may alter the response to oral anticoagulants in man. Phenylbutazone and its congeners are probably the most widely recognized drugs capable of enhancing the hypoprothrombinemic action of oral anticoagulants. Other drugs which may enhance the anticoagulant response include acetaminophen, antibiotics, clofibrate, diphenylhydantoin, disulfiram, indomethacin, methylphenidate hydrochloride, methandrostenolone and norethandrolone, phenyramidol hydrochloride, quinidine and quinine, salicylates, thiouracils, and dextrothyroxine sodium. Conversely, barbiturates may decrease the anticoagulant effect of coumarin drugs and necessitate larger doses for effective anticoagulation. The failure to anticipate a reduced coumarin requirement when the barbiturate is discontinued may result in excessive anticoagulation. A similar effect has been demonstrated for the following drugs: antacids, chloral hydrate, cholestyramine resin, corticosteroids, ethchlorvynol, glutethimide, griseofulvin, haloperidol, meprobamate, and contraceptives administered orally. Mechanisms responsible for these interactions have been elucidated for a number of drugs.^1-10 Numerous case reports confirm bleeding complications . . . [Full Text PDF of this Article]

Author Affiliations
Rochester, NY

From the University of Rochester School of Medicine, Rochester, NY. Dr. Kleinman is now with the University of Pittsburgh School of Medicine, Pittsburgh. Dr. Griner is a fellow of the Life Insurance Foundation in Health Care Administration.

Footnotes
Received for publication Dec 5, 1969; accepted March 12,1970.

Reprint requests to 260 Crittenden Blvd, Rochester, NY 14620 (Dr. Griner).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?